Challenging the 99th percentile: A lower troponin cutoff leads to low mortality of chest pain patients

International Journal of Cardiology

Volumn 232, Issue , 2017, Pages 289-293

  Sörensen, Nils Arne ^a   Neumann, Johannes Tobias ^a,b   Ojeda, Francisco ^a,b   Schwemer, Tjark ^a   Renné, Thomas ^c,d   Schnabel, Renate B ^a,b   Zeller, Tanja ^a,b   Karakas, Mahir ^a,b   Blankenberg, Stefan ^a,b   Westermann, Dirk ^a,b  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

99th percentile; Acute coronary syndrome; Outcome; Troponin

Indexed keywords

TROPONIN; BIOLOGICAL MARKER; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ALGORITHM; ARTICLE; CARDIAC PATIENT; CARDIAC TROPONIN 1 CLIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; REFERENCE VALUE; SENSITIVITY ANALYSIS; SMOKING; THORAX PAIN; ACUTE DISEASE; BLOOD; CAUSE OF DEATH; EPIDEMIOLOGY; GERMANY; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; TRENDS;

ACUTE DISEASE; AGED; ALGORITHMS; BIOMARKERS; CAUSE OF DEATH; CHEST PAIN; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TROPONIN I;

EID: 85009499708     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.12.167     Document Type: Article

References (22)

1. [1] Roffi, M., Patrono, C., Collet, J.-P., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J., 2015, ehv320, 10.1093/eurheartj/ehv320.
2. [2] Neumann, J.T., Sörensen, N.A., Schwemer, T., et al. Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. JAMA Cardiol. 306 (2016), 2684–2693.
3. [3] Reichlin, T., Schindler, C., Drexler, B., et al. One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T. Arch. Intern. Med., 172(16), 2012, 1211.
4. [4] Shah AS V, Anand A, Sandoval Y, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet (London, England) Published Online First: 7 October 2015. doi: 10.1016/S0140-6736(15)00391-8.
5. [5] Eggers, K.M., Aldous, S., Greenslade, J.H., et al. Two-hour diagnostic algorithms for early assessment of patients with acute chest pain–implications of lowering the cardiac troponin I cut-off to the 97.5th percentile. Clin. Chim. Acta 445 (2015), 19–24.
6. [6] Rubini Giménez, M., Hoeller, R., Reichlin, T., et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int. J. Cardiol. 168 (2013), 3896–3901.
7. [7] Zeller, T., Tunstall-Pedoe, H., Saarela, O., et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM biomarker project Scottish cohort. Eur. Heart J. 35 (2014), 271–281.
8. [8] Zeller, T., Ojeda, F., Brunner, F.J., et al. High-sensitivity cardiac troponin I in the general population–defining reference populations for the determination of the 99th percentile in the Gutenberg health study. Clin. Chem. Lab. Med. 53 (2015), 699–706.
9. [9] Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes. J. Am. Coll. Cardiol. 64 (2014), e139–e228.
10. [10] Rubini Gimenez, M., Twerenbold, R., Jaeger, C., et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am. J. Med. 128 (2015), 861–870.e4.
11. [11] Neumann, J.T., Sörensen, N.A., Ojeda, F., Immediate rule-out of acute myocardial infarction using electrocardiogram and baseline high-sensitivity troponin I. Clin. Chem. 63:1 (2017), 394–402.
12. [12] Nestelberger, T., Wildi, K., Boeddinghaus, J., et al. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0 h/1 h-algorithm for the early diagnosis of acute myocardial infarction. Int. J. Cardiol. 207 (2016), 238–245.
13. [13] Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Eur. Heart J. 33 (2012), 2551–2567.
14. [14] Saaby, L., Poulsen, T.S., Hosbond, S., et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am. J. Med. 126 (2013), 789–797.
15. [15] Pfortmueller, C.A., Funk, G.-C., Marti, G., et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. Am. J. Cardiol. 112 (2013), 1968–1972.
16. [16] Chenevier-Gobeaux, C., Meune, C., Freund, Y., et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Am. J. Cardiol. 111 (2013), 1701–1707.
17. [17] Haaf, P., Reichlin, T., Twerenbold, R., et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur. Heart J. 35 (2014), 365–375.
18. [18] Mazhar, J., Killion, B., Liang, M., et al. Chest pain unit (CPU) in the management of low to intermediate risk acute coronary syndrome: a tertiary hospital experience from New Zealand. Hear Lung Circ. 22 (2013), 110–115.
19. [19] Nagarajan, V., Hernandez, A.V., Tang, W.H.W., Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 98 (2012), 1778–1786.
20. [20] Giannitsis, E., Katus, H.A., Cardiac troponin level elevations not related to acute coronary syndromes. Nat. Rev. Cardiol. 10 (2013), 623–634.
21. [21] Omland, T., Pfeffer, M.A., Solomon, S.D., et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease for the PEACE investigators. J. Am. Coll. Cardiol. 61 (2013), 1240–1249.
22. [22] Blankenberg S, Salomaa V, Makarova N, et al. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium for the BiomarCaRE Investigators. http://dx.doi.org/10.1093/eurheartj/ehw172.